First Turn Management »

Somalogic shares owned by First Turn Management

Quarter-by-quarter ownership of Somalogic shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Somalogic

Tip: Access up to 7 years of quarterly data

All positions including Somalogic held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Somalogic by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2k 18k 0.12

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Somalogic

D. E. Shaw & Co
LMR Partners
CSS
Gagnon Securities
Millennium Management
Deerfield Management Company
T. Rowe Price Associates
Gagnon Advisors
Saba Capital Management
Two Sigma Investments
Fort Baker Capital Management
Jpmorgan Chase & Co
Wolverine Asset Management
TD Asset Management
Bleichroeder

View all funds holding Somalogic